Tourney Fungicide

SECTION 2: Hazards identification

Emergency Overview CAUTION • Keep out of reach of children • Harmful if swallowed • Avoid contact with eyes, skin and clothing • Avoid breathing mist or vapours • May cause skin and respiratory irritation • May cause moderate eye irritation

Potential health effects

Acute Toxicity (Primary Routes of Exposure): None known Acute Eye Contact: This product can cause brief and/or minor eye irritation. The expected adverse health effects resulting from an exposure may include redness and possible swelling. Acute Skin Contact: This product may cause minor skin irritation and / or short term. If exposed, the expected adverse health effects may include irritation and possibly a slight inflammation. This product is minimally toxic when absorbed through the skin. This product is not expected to cause allergic skin reactions. Acute Ingestion: This product is slightly toxic when ingested. Acute Inhalation: This product is minimally toxic when inhaled. Exposure to high concentrations in the air may result in respiratory irritation. Signs and symptoms may include, but not be limited to, nasal discharge, sore throat, coughing and difficulty in breathing. ______________________________________________________________________________________________ Chronic Toxicity (including cancer): In long-term (> 28 days) studies, Metconazole Fungicide Technical produced toxic effects on the liver, blood, spleen, kidney and gastrointestinal tract. Increased liver adenomas and adenocarcinomas were observed in mice, but these tumors are unlikely to be relevant to humans. This material contains a small amount of crystalline silica. Repeated inhalation of large amounts of silica dust over an extended period of time may result in a progressive, disabling disease, silicosis. The International Agency for Research on Cancer (IARC) has determined that respirable crystalline silica is carcinogenic to humans. The National Toxicology Program (NTP) classifies respirable crystalline silica as a known carcinogen. Developmental Toxicity (birth defects): At doses producing maternal toxicity malformations were observed in the fetuses of rats and rabbits treated with Metconazole Fungicide Technical during gestation. Reproductive toxicity: Metconazole Fungicide Technical was tested in a 2-generation rat reproduction study. At maternally toxic doses, effects were noted on estrus cycling, litter size, gestation length and pup body weight. Signs and Symptoms of Systemic Effects: no data available Potentially Aggravated Medical Conditions: Individuals with preexisting diseases of the liver or blood may have increased susceptibility to the toxicity of excessive exposures. For complete discussion of the toxicology data from which this evaluation was made, refer to Section 11. For Ecotox/Environmental Information, refer to Section 12. For Regulatory Information, refer to Section 15.